HCMT
AUPH icon

Highland Capital Management (Texas)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Highland Capital Management (Texas)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200,000
Closed -$1.47M – 292
2017
Q1 		$1.47M Buy
+200,000
New +$924K 0.07% 174

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Highland Capital Management (Texas)'s AUPH Position: Q2 2017 in Review

Highland Capital Management (Texas) sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2017, closing a stake of 200,000 shares — an estimated $1.47M sold.

Highland Capital Management (Texas) first reported a position in AUPH in Q1 2017 and held it in 1 quarter. The position peaked at $1.47M in Q1 2017. 65 funds tracked by Wall St. Rank hold AUPH as of Q2 2017.

  • Highland Capital Management (Texas) reported no remaining Aurinia Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 200,000 Aurinia Pharmaceuticals shares in Q2 2017, an estimated $1.47M.
  • Highland Capital Management (Texas) first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Aurinia Pharmaceuticals position peaked at $1.47M in Q1 2017.
  • 65 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2017, filed 14 Aug 2017.